Fig. 7
The decond derivative spectrum of 30.00 μg/mL of trimebutine maleate and 30.00 μg/mL of its alkali-induced degradation products measured at 268 nm at the zero-crossing point
Fig. 7 | Future Journal of Pharmaceutical Sciences
The decond derivative spectrum of 30.00 μg/mL of trimebutine maleate and 30.00 μg/mL of its alkali-induced degradation products measured at 268 nm at the zero-crossing point